These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 9847257

  • 1. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.
    Praticò D, Basili S, Vieri M, Cordova C, Violi F, Fitzgerald GA.
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1709-14. PubMed ID: 9847257
    [Abstract] [Full Text] [Related]

  • 2. Enhanced in vivo lipid peroxidation in scleroderma spectrum disorders.
    Cracowski JL, Marpeau C, Carpentier PH, Imbert B, Hunt M, Stanke-Labesque F, Bessard G.
    Arthritis Rheum; 2001 May; 44(5):1143-8. PubMed ID: 11352247
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increased urinary F2-isoprostanes in patients with Crohn's disease.
    Cracowski JL, Bonaz B, Bessard G, Bessard J, Anglade C, Fournet J.
    Am J Gastroenterol; 2002 Jan; 97(1):99-103. PubMed ID: 11808977
    [Abstract] [Full Text] [Related]

  • 5. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group.
    Davì G, Basili S, Vieri M, Cipollone F, Santarone S, Alessandri C, Gazzaniga P, Cordova C, Violi F.
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1794-9. PubMed ID: 9412557
    [Abstract] [Full Text] [Related]

  • 6. Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans.
    Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, Lawson JA, FitzGerald GA.
    Circulation; 1997 Nov 18; 96(10):3314-20. PubMed ID: 9396422
    [Abstract] [Full Text] [Related]

  • 7. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.
    Davi G, Alessandrini P, Mezzetti A, Minotti G, Bucciarelli T, Costantini F, Cipollone F, Bon GB, Ciabattoni G, Patrono C.
    Arterioscler Thromb Vasc Biol; 1997 Nov 18; 17(11):3230-5. PubMed ID: 9409316
    [Abstract] [Full Text] [Related]

  • 8. In vivo lipid peroxidation and platelet activation in cystic fibrosis.
    Ciabattoni G, Davì G, Collura M, Iapichino L, Pardo F, Ganci A, Romagnoli R, Maclouf J, Patrono C.
    Am J Respir Crit Care Med; 2000 Oct 18; 162(4 Pt 1):1195-201. PubMed ID: 11029317
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease.
    Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommasoli R, Seta F, Capone ML, Tacconelli S, Palatresi S, Bencini C, Del Vecchio C, Mansueto G, Arosio E, Santonastaso CL, Lechi A, Morganti A, Patrono C.
    Circulation; 2002 Nov 26; 106(22):2800-5. PubMed ID: 12451006
    [Abstract] [Full Text] [Related]

  • 15. Platelet activation and lipid peroxidation in patients with acute ischemic stroke.
    van Kooten F, Ciabattoni G, Patrono C, Dippel DW, Koudstaal PJ.
    Stroke; 1997 Aug 26; 28(8):1557-63. PubMed ID: 9259748
    [Abstract] [Full Text] [Related]

  • 16. Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA.
    Iuliano L, Praticò D, Greco C, Mangieri E, Scibilia G, FitzGerald GA, Violi F.
    J Am Coll Cardiol; 2001 Jan 26; 37(1):76-80. PubMed ID: 11153776
    [Abstract] [Full Text] [Related]

  • 17. Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress.
    Ferrante E, Vazzana N, Santilli F, Di Cicco M, Lauriti C, Di Battista L, Ciabattoni G, Di Matteo L, Davì G.
    Free Radic Biol Med; 2010 Sep 01; 49(5):857-64. PubMed ID: 20541603
    [Abstract] [Full Text] [Related]

  • 18. Enhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotype.
    Vazzana N, Ganci A, Cefalù AB, Lattanzio S, Noto D, Santoro N, Saggini R, Puccetti L, Averna M, Davì G.
    J Am Heart Assoc; 2013 Apr 04; 2(2):e000063. PubMed ID: 23557750
    [Abstract] [Full Text] [Related]

  • 19. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study.
    Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brümmer J, Gutzki FM, Berger J, Frölich JC, Böger RH.
    Circulation; 2004 Feb 24; 109(7):843-8. PubMed ID: 14757688
    [Abstract] [Full Text] [Related]

  • 20. Systemic oxidative stress in asthma, COPD, and smokers.
    Rahman I, Morrison D, Donaldson K, MacNee W.
    Am J Respir Crit Care Med; 1996 Oct 24; 154(4 Pt 1):1055-60. PubMed ID: 8887607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.